Pradaxa ® gains EU approval for treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism

Pradaxa ® gains EU approval for treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news